Cargando…
Identification of Activated Cdc42-Associated Kinase Inhibitors as Potential Anticancer Agents Using Pharmacoinformatic Approaches
Background: Activated Cdc42-associated kinase (ACK1) is essential for numerous cellular functions, such as growth, proliferation, and migration. ACK1 signaling occurs through multiple receptor tyrosine kinases; therefore, its inhibition can provide effective antiproliferative effects against multipl...
Autores principales: | Kumar, Vikas, Kumar, Raj, Parate, Shraddha, Danishuddin, Lee, Gihwan, Kwon, Moonhyuk, Jeong, Seong-Hee, Ro, Hyeon-Su, Lee, Keun Woo, Kim, Seon-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953130/ https://www.ncbi.nlm.nih.gov/pubmed/36830587 http://dx.doi.org/10.3390/biom13020217 |
Ejemplares similares
-
Identification of CDK7 Inhibitors from Natural Sources Using Pharmacoinformatics and Molecular Dynamics Simulations
por: Kumar, Vikas, et al.
Publicado: (2021) -
Investigating natural compounds against oncogenic RET tyrosine kinase using pharmacoinformatic approaches for cancer therapeutics
por: Parate, Shraddha, et al.
Publicado: (2022) -
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021) -
Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer
por: Danishuddin,, et al.
Publicado: (2021) -
3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
por: Kumar, Vikas, et al.
Publicado: (2022)